+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), By Application, By Region, And Segment Forecasts, 2022 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702205
Description Jump to:
The global breast cancer liquid biopsy market size is expected to reach USD 1.7 billion by 2030, expandingat a CAGR of 22.7% from 2022 to 2030. The growth is attributed to the rising preference for non-invasive methods, rising awareness of early diagnosis and treatment, and rising prevalence of breast cancer. For instance, according to WHO, in 2020, globally, 685,000 women lost their lives to breast cancer, and 2.3 million women were affected by it. Liquid biopsies have been suggested as a revolutionary technique for the early identification of breast cancer, which boosts its adoption and spurs growth.

With the increasing prevalence of breast cancer, there is a high demand to provide proper diagnostics tools for detecting cancer at an early stage and early treatment. There has been increasing R&D in the field of diagnostics to cater to the rising demand. For instance, in June 2022, according to study findings from BioFluidica, patients with HER2-positive breast cancer had success rates while receiving tailored HER2-directed therapy.The clinical significance of liquid biopsy is becoming more well-known as a result of ongoing developments in related fields. Additional interventional clinical trials and the creation of an algorithm to properly combine circulating biomarkers are required to make these technologies widely accessible.

A less intrusive technique for identifying non-hematological malignancies has been developed as a result of technological breakthroughs in continuing research on circulating biomarkers. Compared to traditional tumor biopsy, liquid biopsy is thought to be a promising option for patient monitoring in real time. For instance, in April 2022, Epic Sciences, Inc., launched DefineMBC, a blood test based on liquid biopsy technology for the diagnosis of metastatic breast cancer to its CLIA laboratory portfolio.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in June 2022, NeoGenomics’s subsidiary Inivata Limited announced new data for RaDaR assay for the analysis of human epidermal growth factor receptor 2 (HER2)-negative, high-risk patients with minimal residual disease (MRD) and recurrence.

Breast Cancer Liquid Biopsy Market Report Highlights

  • In 2021, the circulating tumor cells segment held a dominant revenue share owing to the effectiveness and precision offered by CTCs in the detection of cancer
  • The early detection segment is projected to grow at the fastest CAGR over the forecast period, owing to the increasing adoption of liquid biopsy in early diagnosis of cancer and the rising need to provide effective treatment
  • Treatment selection was the highest revenue-generating segment in 2021 owing to the availability of a high number of products that aid treatment selection
  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to increasing prevalence, improving healthcare infrastructure, and growing population


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country - Wise Market Estimation Using Bottom - Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Breast Cancer Liquid Biopsy Market Variables, Trends, & Scope
3.1 Breast Cancer Liquid Biopsy Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (Ivd) Market
3.2 Penetration And Growth Prospect Mapping
3.3 Market Dynamics
3.4 Market Driver Analysis
3.4.1 Increasing Prevalence Of Breast Cancer
3.4.2 Increasing Adoption Of Liquid Biopsies In Cancer Diagnosis
3.4.3 Need To Provide Early Diagnosis And Treatment
3.5 Market Restraint Analysis
3.5.1 High Cost Associated With Breast Cancer Liquid Biopsy Tests
3.5.2 Regulatory & Reimbursement Hurdles
3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 Breast Cancer Liquid Biopsy Market - Segment Analysis, By Circulating Biomarkers, 2018 - 2030 (USD Million)
4.1 Breast Cancer Liquid Biopsy Market: Circulating Biomarkers Movement Analysis
4.1.1 Circulating Tumor Cells (Ctcs)
4.1.1.1 Circulating Tumor Cells (Ctcs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.2 Circulating Cell - Free Dna (Cfdna)
4.1.2.1 Circulating Cell - Free Dna (Cfdna) Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.3 Extracellular Vesicles (Evs)
4.1.3.1 Extracellular Vesicles (Evs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.1.4 Other Circulating Biomarkers
4.1.4.1 Other Circulating Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Breast Cancer Liquid Biopsy Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
5.1 Breast Cancer Liquid Biopsy Market: Application Movement Analysis
5.1.1 Early Detection/Screening
5.1.1.1 Early Detection/Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.2 Diagnosis
5.1.2.1 Diagnosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.3 Treatment Selection
5.1.3.1 Treatment Selection Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.1.4 Monitoring
5.1.4.1 Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Breast Cancer Liquid Biopsy Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
6.1 Breast Cancer Liquid Biopsy Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 Australia
6.4.4.1 Australia Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.5.3 Argentina
6.5.4.1 Argentina Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.6 Mea
6.6.1 Mea Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
Chapter 7 Breast Cancer Liquid Biopsy Market: Competitive Analysis
7.1 Recent developments and impact analysis, by key market participants
7.1.1 Ansoff Matrix
7.1.2 Major Deals And Strategic Alliances Analysis
7.1.2.1 Market Expansion
7.1.2.2 Product Launch
7.1.2.3 Acquisition
7.1.2.4 Partnerships And Collaborations
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Key Customers
7.3.3 Key Company Market Share Analysis, 2021
7.4 Public Companies
7.4.1 Company Market Position Analysis
7.4.2 Heat Map Analysis
7.4.3 Regional Network Map
7.4.4 Competitive Dashboard Analysis
7.4.4.1 Market Differentiators
7.5 Private Companies
7.5.1 List Of Key Emerging Companies
7.5.2 Heat Map Analysis
7.5.3 Regional Network Map
Chapter 8 Company Profiles
8.1 The Menarini Group
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 NeoGenomics Laboratories
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 F. Hoffmann - La Roche Ltd.,
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.2 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Myriad Genetics, Inc.
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 QIAGEN
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.2 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Biocept, Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.9 Fluxion Biosciences, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Epic Sciences, Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Regulatory framework
TABLE 4 Global breast cancer liquid biopsy market, by region, 2018 - 2030 (USD Million)
TABLE 5 Global breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 6 Global breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 7 North America breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 8 North America breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 9 North America breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 10 U.S. breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 11 U.S. breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 12 Canada breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 13 Canada breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 14 Europe breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 15 Europe breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 16 Europe breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 17 U.K. breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 18 U.K. breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 19 Germany breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 20 Germany breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 21 Spain breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 22 Spain breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 23 France breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 24 France breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 25 Italy breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 26 Italy breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 27 Asia Pacific breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 28 Asia Pacific breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 29 Asia Pacific breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 30 Japan breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 31 Japan breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 32 China breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 33 China breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 34 India market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 35 India breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 36 Australia market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 37 Australia breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 38 South Korea market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 39 South Korea breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 40 South Korea breast cancer liquid biopsy market, by product circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 41 Latin America breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 42 Latin America breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 43 Latin America breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 44 Brazil breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 45 Brazil breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 46 Mexico breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 47 Mexico breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 48 Argentina breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 49 Argentina breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 50 MEA breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 51 MEA breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 52 MEA breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 53 South Africa breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 54 South Africa breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 55 Saudi Arabia breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 56 Saudi Arabia breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 57 UAE breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 58 UAE breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Breast cancer liquid biopsy market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value - chain - based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Breast cancer liquid biopsy market snapshot
FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
FIG. 11 Market Dynamics
FIG. 12 Breast cancer liquid biopsy market driver impact
FIG. 13 Enzymes in the diagnosis of diseases
FIG. 14 Common applications of enzymes in pathology
FIG. 15 Breast cancer liquid biopsy market restraint impact
FIG. 16 Porter’s five forces analysis
FIG. 17 Breast cancer liquid biopsy market: Circulating biomarkers outlook and key takeaways
FIG. 18 Circulating tumor Cells (CTCs) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 19 Circulating cell - free DNA (cfDNA) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 20 Extracellular Vesicles (EVs) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 21 Others circulating biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 22 Breast cancer liquid biopsy market: Application outlook and key takeaways
FIG. 23 Breast cancer liquid biopsy market: Application movement analysis
FIG. 24 Early detection/screening market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 25 Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 26 Treatment selection market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 27 Monitoring market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 28 Breast cancer liquid biopsy Market: Regional outlook and key takeaways
FIG. 29 Breast cancer liquid biopsy: Regional movement analysis
FIG. 30 North America
FIG. 31 North America. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 32 U.S.
FIG. 33 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 34 Canada
FIG. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 36 Europe
FIG. 37 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 38 UK
FIG. 39 UK market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 40 Germany
FIG. 41 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 France
FIG. 43 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Spain
FIG. 45 Spain market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 Italy
FIG. 47 Italy market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 Asia Pacific
FIG. 49 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Japan
FIG. 51 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 China
FIG. 53 China. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 India
FIG. 55 India market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 Australia
FIG. 57 Australia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 58 South Korea
FIG. 59 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 60 Latin America
FIG. 61 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 62 Brazil
FIG. 63 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 64 Mexico
FIG. 65 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 66 Argentina
FIG. 67 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 68 MEA
FIG. 69 MEA market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 70 South Africa
FIG. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 72 Saudi Arabia
FIG. 73 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 74 UAE
FIG. 75 UAE market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 76 Ansoff Matrix
FIG. 77 Strategy mapping
FIG. 78 Company market share analysis, 2021
FIG. 79 Heat map analysis
FIG. 80 Market differentiators
FIG. 81 Heat map analysis
FIG. 82 Regional network map

Companies Mentioned

  • The Menarini Group
  • Neogenomics Laboratories
  • F. Hoffmann - La Roche Ltd.
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen
  • Biocept, Inc.
  • Sysmex Corporation
  • Fluxion Biosciences, Inc.
  • Epic Sciences, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages130
PublishedNovember 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 317.89 Million
Forecasted Market Value ( USD ) by 2030 $ 1700 Million
Compound Annual Growth Rate22.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Forecast 2024-2030 - Product Image

Global Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Forecast 2024-2030 - Product Image

Global Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Breast Cancer Liquid Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Breast Cancer Liquid Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Liquid Biopsy Market - Global Liquid Biopsy Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 (By Biomarker, By Source, By Clinical Application, By Indication, By Geographic Coverage and By Company) - Product Image

Liquid Biopsy Market - Global Liquid Biopsy Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 (By Biomarker, By Source, By Clinical Application, By Indication, By Geographic Coverage and By Company)

  • Report
  • 210 Pages
  • Global
Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-users, Stage of Development, Type of Product, Type of Technique, Application Area and Key Geographical Regions - Product Image

Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-users, Stage of Development, Type of Product, Type of Technique, Application Area and Key Geographical Regions

  • Report
  • 331 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.